Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc-AndrÉ Gagnon

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
Corruption of pharmaceutical markets: addressing the misalignment of financial incentives and public healthMarc-André Gagnon
Healthcare Policy = Politiques De Sante|May 2, 2013
Drug shortages: searching for a cureMarc-André Gagnon
Healthcare Policy = Politiques De Sante|March 14, 2023
Commentary: Reconsidering Pharmaceutical Research and Development InvestmentsMarc-André Gagnon
Healthcare Policy = Politiques De Sante|September 4, 2024
Commentary: Which Principles Should Apply for a National Strategy on Rare Diseases?Marc-AndrÉ Gagnon
International Journal of Health Policy and Management|July 3, 2020
Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"Marc-André Gagnon
The Journal of Physical Chemistry. B|June 16, 2009
Self-diffusion and mutual diffusion of small molecules in high-set curdlan hydrogels studied by 31P NMRMarc-André Gagnon, Michel Lafleur
Applied Spectroscopy|April 26, 2007
From curdlan powder to the triple helix gel structure: an attenuated total reflection-infrared study of the gelation processMarc-André Gagnon, Michel Lafleur
Health Policy (Amsterdam, Netherlands)|September 23, 2018
Surviving niche busters: Main strategies employed by Canadian private insurers facing the arrival of high cost specialty drugsMathieu Charbonneau, Marc-André Gagnon
Pharmaceutical Development and Technology|August 7, 2010
Comparison between nuclear magnetic resonance profiling and the source/sink approach for characterizing drug diffusion in hydrogel matricesMarc-André Gagnon, Michel Lafleur
Plos One|January 2, 2025
Unveiling chemical industry secrets: Insights gleaned from scientific literatures that examine internal chemical corporate documents-A scoping reviewMiaoran Dong, Marc-André Gagnon
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
Corruption of pharmaceutical markets: addressing the misalignment of financial incentives and public healthMarc-André Gagnon
Healthcare Policy = Politiques De Sante|May 2, 2013
Drug shortages: searching for a cureMarc-André Gagnon
Healthcare Policy = Politiques De Sante|March 14, 2023
Commentary: Reconsidering Pharmaceutical Research and Development InvestmentsMarc-André Gagnon
Healthcare Policy = Politiques De Sante|September 4, 2024
Commentary: Which Principles Should Apply for a National Strategy on Rare Diseases?Marc-AndrÉ Gagnon
International Journal of Health Policy and Management|July 3, 2020
Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"Marc-André Gagnon
The Journal of Physical Chemistry. B|June 16, 2009
Self-diffusion and mutual diffusion of small molecules in high-set curdlan hydrogels studied by 31P NMRMarc-André Gagnon, Michel Lafleur
Applied Spectroscopy|April 26, 2007
From curdlan powder to the triple helix gel structure: an attenuated total reflection-infrared study of the gelation processMarc-André Gagnon, Michel Lafleur
Health Policy (Amsterdam, Netherlands)|September 23, 2018
Surviving niche busters: Main strategies employed by Canadian private insurers facing the arrival of high cost specialty drugsMathieu Charbonneau, Marc-André Gagnon
Pharmaceutical Development and Technology|August 7, 2010
Comparison between nuclear magnetic resonance profiling and the source/sink approach for characterizing drug diffusion in hydrogel matricesMarc-André Gagnon, Michel Lafleur
Plos One|January 2, 2025
Unveiling chemical industry secrets: Insights gleaned from scientific literatures that examine internal chemical corporate documents-A scoping reviewMiaoran Dong, Marc-André Gagnon
Pageof 3